CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · Real-Time Price · USD
0.0561
+0.0021 (3.89%)
At close: Dec 20, 2024, 4:00 PM
0.0557
-0.0004 (-0.71%)
After-hours: Dec 20, 2024, 7:59 PM EST
CERO Employees
As of December 31, 2023, CERo Therapeutics Holdings had 9 total employees, including 8 full-time and 1 part-time employees.
Employees
9
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$609,795
Market Cap
8.43M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Meihua International Medical Technologies | 617 |
| XWELL | 337 |
| Evogene | 142 |
| RedHill Biopharma | 53 |
| Viracta Therapeutics | 40 |
| Purple Biotech | 20 |
| Aethlon Medical | 14 |
| COSCIENS Biopharma | 12 |
CERO News
- 15 days ago - CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO - GlobeNewsWire
- 5 weeks ago - CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia - GlobeNewsWire
- 5 weeks ago - CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity - GlobeNewsWire
- 2 months ago - CERo Therapeutics, Inc. Provides Corporate Update - GlobeNewsWire
- 2 months ago - CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer - GlobeNewsWire
- 3 months ago - Dow Tumbles Over 200 Points; CERo Therapeutics Shares Jump - Benzinga
- 3 months ago - CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236 - GlobeNewsWire
- 5 months ago - Top 3 Health Care Stocks Which Could Rescue Your Portfolio In July - Benzinga